The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

In today’s ACT Brief, we cover how AI is being deployed to optimize global trial design, why ESG performance is emerging as a core vendor qualification signal, and how sites are becoming more ...

Forbes contributors publish independent expert analyses and insights. I write about the application of AI & Big Data to innovation and prediction. Feb 22, 2024, 03:42am EST Clinical trials are ...

Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...

A Swiss startup called Risklick has launched artificial intelligence software for clinical trials that the company claims can reduce development time and costs by as much as 35%, according to an April ...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and ...

AstraZeneca has launched a new company to allow CROs and fellow Big Pharmas to pay to access its tried-and-tested digital solutions for running clinical trials. The standalone company, called Evinova, ...

A significant unmet need exists for new and effective treatments for urothelial cancers (UCs). To identify optimal treatment options and improve outcomes for patients, trial design is of utmost ...